Cargando…
Editorial: Novel Small-Molecule Agents in Overcoming Multidrug Resistance in Cancers
Autores principales: | Cui, Qingbin, Wang, Cong, Zeng, Leli, Zhou, Qian-Xiong, Fan, Ying-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114663/ https://www.ncbi.nlm.nih.gov/pubmed/35601552 http://dx.doi.org/10.3389/fchem.2022.921985 |
Ejemplares similares
-
Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer
por: Yu, Hui-Jing, et al.
Publicado: (2021) -
Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
por: Zhang, Guan-Nan, et al.
Publicado: (2020) -
Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023) -
Editorial: Small organic molecules with anticancer activity
por: Rahman, A. F. M. Motiur, et al.
Publicado: (2023) -
Apoptosis-independent organoruthenium anticancer complexes that overcome multidrug resistance: self-assembly and phenotypic screening strategies
por: Chow, Mun Juinn, et al.
Publicado: (2017)